Vancomycin Hydrochloride (Under Development)

Vancomycin Hydrochloride is a key API for the clinical treatment of severe Gram-positive bacterial infections. As a narrow-spectrum and high-efficiency antibiotic, it exerts potent antibacterial activity exclusively against Gram-positive bacteria.

Its antibacterial spectrum covers common susceptible strains such as Streptococcus haemolyticus, Streptococcus pneumoniae and Enterococcus, and demonstrates outstanding activity especially against multidrug-resistant Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA), making it a critical therapeutic option for combating drug-resistant bacterial infections.